Abstract
Objective Sepsis is a common cause of death in hospitalized patients. The Centers for Medicare & Medicaid Service (CMS) Severe Sepsis and Septic Shock Bundle (SEP-1) is an evidence-based early management bundle focused on improving sepsis outcomes. It is unknown which quality improvement (QI) practices are associated with SEP-1 compliance and if those practices reduce sepsis mortality. The objectives of this study were to compare sepsis QI practices in SEP-1 reporting and non-reporting hospitals and to measure the association between specific elements of sepsis QI processes and SEP-1 performance and hospital-specific risk-adjusted sepsis mortality.
Design, Setting, and Patients This mixed methods study linked telephone survey data on QI practices from Iowa hospitals to SEP-1 performance data and risk-adjusted mortality from statewide all-payer administrative claims database. The survey assessed sepsis QI practices in eight categories. Characteristics of hospitals and sepsis QI practices were compared by SEP-1 reporting status. Univariable and multivariable logistic and linear regression estimated the association of QI practices with hospital SEP-1 performance and observed-to-expected sepsis mortality ratios.
Interventions None
Measurements and Main Results All 118 Iowa hospitals completed the survey (100% response rate). SEP-1 reporting hospitals were more likely to have sepsis QI practices, including reporting sepsis quality to providers (64% vs. 38%, p = 0.026) and using the case review process to develop sepsis care plans (87% vs. 64%, p = 0.013). Sepsis QI practices were not associated with increased SEP-1 scores. Two were associated with reduced mortality: having a sepsis committee β= -0.11, p = 0.036) and using case review results for sepsis care plans (β= -0.10, p = 0.049).
Conclusions Hospitals reporting SEP-1 compliance to CMS conduct more sepsis QI practices. Most QI practices are not associated with increased SEP-1 performance or decreased sepsis mortality. Future work could explore how to implement these performance improvement practices in hospitals not reporting SEP-1 compliance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding was supported by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (T35 HL007485), the University of Iowa Institute for Clinical and Translational Sciences funded by a grant from the National Center for Advancing Translational Sciences (U54TR001356), and the University of Iowa Department of Emergency Medicine. Ms. Swanson is additionally supported by a grant from the National Center for Child Health and Human Development (F30HD100074) and Dr. Mohr is additionally supported by a grant from the Agency for Healthcare Research and Quality (K08 HS025753). These contents are solely the responsibility of the authors and do not necessarily reflect the views of the National Institutes of Health, the Agency for Healthcare Research and Quality, or the U.S. Department of Health and Human Services.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human Subjects Office / IRB Hardin Library, Office 105 600 Newton Rd Iowa City, IA 52242-1098 Voice: 319-335-6564 Fax: 319-335-7310 irb{at}uiowa.edu
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Funding was supported by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (T35 HL007485), the University of Iowa Institute for Clinical and Translational Sciences funded by a grant from the National Center for Advancing Translational Sciences (U54TR001356), and the University of Iowa Department of Emergency Medicine. Ms. Swanson is additionally supported by a grant from the National Center for Child Health and Human Development (F30HD100074) and Dr. Mohr is additionally supported by a grant from the Agency for Healthcare Research and Quality (K08 HS025753). These contents are solely the responsibility of the authors and do not necessarily reflect the views of the National Institutes of Health, the Agency for Healthcare Research and Quality, or the U.S. Department of Health and Human Services.
Conflicts of Interest: No conflicts of interest were declared.
Authors’ Contribution: TBB, MBS, AA, NMM, and JM conceived the study, MBS and NMM designed the analysis and interpreted the results. Surveys were conducted by TBB and AK. TBB, MBS, AK, NMM, JM, and AA drafted the manuscript, created figures and tables, and provided revisions. MBS conducted the statistical analysis, and all authors interpreted the statistical analysis. All authors take responsibility for the data and approved the final manuscript.
Institution Where the Work was Performed: University of Iowa Carver College of Medicine, Iowa City, Iowa
Reprints will not be available.
Prior Presentations: This study was presented in abstract form at the Society for Academic Emergency Medicine Annual Meeting on May 12, 2021
Data Availability
SEP-1 score data were obtained from the CMS Hospital Compare public website for the reporting periods of April 2018 to March 2019. State hospital association data containing administrative claims for all adults (18 years) treated in a hospital within the state between 2015 to 2019 were used to estimate sepsis risk-adjusted mortality by hospital.
